Elixinol Wellness Limited (ASX:EXL)

Australia · Delayed Price · Currency is AUD

0.0070

0.00 (0.00%)

Mar 25, 2026, 3:56 PM AEST

Revenue by Segment

Financials in millions AUD. Fiscal year is January - December.

Millions AUD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Sale of Nutraceutical and Related Hemp Products	15.50M	14.96M	8.27M	7.10M	9.34M
Sale of Nutraceutical and Related Hemp Products Growth	3.64%	80.87%	16.43%	-23.95%	-37.79%
Total	15.50M	14.96M	8.27M	7.10M	9.34M
Total Growth	3.64%	80.87%	16.43%	-23.95%	-37.79%

Revenue by Geography

Financials in millions AUD. Fiscal year is January - December.

Millions AUD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Rest of The World	11.00K	46.00K	44.00K	46.00K	469.00K
Rest of The World Growth	-76.09%	4.55%	-4.35%	-90.19%	-
Australia	13.90M	12.86M	5.59M	3.69M	4.09M
Australia Growth	8.14%	130.14%	51.37%	-9.67%	-1.68%
Americas	1.59M	2.05M	2.64M	3.32M	4.78M
Americas Growth	-22.76%	-22.21%	-20.49%	-30.63%	-43.80%
Total	15.50M	14.96M	8.27M	7.06M	9.34M
Total Growth	3.64%	80.87%	17.21%	-24.45%	-37.79%

Source: S&P Global Market Intelligence.